The Georgian authorities announced the imminent receipt of a vaccine against the Pfizer coronavirus. This was announced on Tuesday, January 12, by Sputnik Georgia.
“We are actively cooperating with the COVAX platform, and we have some progress towards making the Pfizer vaccine available to the population in Georgia in the near future,” said Ekaterina Tikaradze, head of the Ministry of Health.
The ministry added that through COVAX, the authorities ordered a vaccine for 20 percent of the country’s population, that is, for 700 thousand people.
BNT162b2 from the American company Pfizer and its German partner BioNTech became the first vaccine against COVID-19 approved by the European Union.
In December, the Georgian Ministry of Health disclosed the condition for the purchase of the Russian vaccine against coronavirus: the issue will be considered if the drug is approved by the World Health Organization (WHO).
COVAX is a project created by WHO in partnership with the Global Alliance for Vaccines and Immunization and the Coalition for Innovation in Epidemic Preparedness.